Search

everythinglearnresearchcommunity

for

Search:↓

A new mouse model for vitiligo helps study immune responses and potential treatments.

Understanding how baby skin heals without scars could help develop treatments for adults to heal wounds without leaving scars.

Dermal factors are crucial in regulating melanin production in skin.

Tectoridin helps human hair cells grow and makes mouse hair longer, suggesting it could treat hair loss.

Eyelid cells share signaling components but differ in pathway activity.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

A form of vitamin E promotes hair growth by activating a specific skin pathway.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

P-cadherin is important for hair growth and health, and its problems can cause hair and skin disorders.

Fat tissue under the skin affects hair growth and aging; reducing its inflammation may help treat hair loss.

Using both platelet-rich plasma and minoxidil together gives the best results for hair growth in male rats with hair loss.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Cultured dermal papilla cells can regenerate hair follicles and sustain hair growth.

Keratinocytes control how melanocytes work.

The skin is the largest organ, protecting the body, regulating temperature, and producing hormones.

Local injections of nanosized rhEPO can speed up skin healing and improve quality after deep second-degree burns.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

The research suggests that a specific skin gene can be controlled by signals within and between cells and is wrongly activated in certain skin diseases.

Hair color is determined by different melanins and changes with age.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Genetically modified sheep with more β-catenin grew more wool without changing the wool's length or thickness.

Higher levels of MiR-92a-1-5p and miR-328-3p found in female hair loss patients.

The gene HDC is important for the development of hair follicles in newborn mice.